NIH-funded research NIH-funded research

Understanding impulsivity in Parkinson's disease

Official title: Biomarkers of Impulsivity in Parkinson's Disease

Funded at Minneapolis VA Medical Center · NIH-11116831 · Data updated 2026-11-12

This study is looking into why some people with Parkinson's disease might struggle with impulsive behaviors like gambling or overeating, especially how their medications might play a role, so we can find better ways to help improve their lives and support their families.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionMinneapolis VA Medical Center
NIH-funded
Lab location1 site (Minneapolis, United States)
Project startJuly 1, 2019
Project endJune 30, 2025
Funding year2024
NIH project number5I01CX001773-06
Project IDNIH-11116831 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Parkinson's disease who experience impulsivity or impulse control disorders.

Less likely to help

Patients with Parkinson's disease who do not exhibit impulsivity or related disorders may not benefit from this research.

What this research studies

This research investigates the causes and effects of impulsivity in patients with Parkinson's disease, particularly focusing on impulse control disorders such as compulsive gambling and binge eating. It aims to explore how dopamine-replacement therapies contribute to these behaviors and the impact they have on patients' quality of life and their caregivers. By identifying the underlying biological markers associated with impulsivity, the research seeks to develop better treatment strategies that can help manage these complications effectively.

Why it matters

Potential benefit: If successful, this research could lead to improved treatment options for managing impulsivity in Parkinson's disease, enhancing patients' quality of life.

How similar studies have gone: Previous research has indicated a link between dopamine therapies and impulsivity in Parkinson's disease, suggesting that this area of investigation is both relevant and necessary.

Where this research is happening

  • Minneapolis VA Medical Center
    Minneapolis, United States
    Active

Researchers

  • Principal investigator: Pellizzer, Giuseppe — Minneapolis VA Medical Center
  • Study coordinator: Pellizzer, Giuseppe

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.